Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances
2024-01-10
并购
DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to
ResearchAndMarkets.com's offering.
Industry Analysis Unveils Consolidation Dynamics and Regional Market Expansion
The global cord blood and tissue banking industry is undergoing a period of significant transformation characterized by robust merger and acquisition activities, technological innovation, and market expansion.
A new research publication delves into the intricacies of this dynamic market, offering in-depth insights into current trends, future projections, and strategic developments through 2030.
Amidst the spotlight on the healthcare sector for tailored and advanced therapeutic solutions, cord blood and tissue banking has emerged as a pivotal component. Cord blood, known for its potent hematopoietic stem cells, has a track record of over 40,000 transplants worldwide, heralding a new era in treatment options for a myriad of diseases.
This comprehensive analysis not only highlights the milestones achieved in cord blood and tissue transplants but also sheds light on the storage capabilities of both public and private banks worldwide.
Strategic Developments and Market Segmentation
Public and private cord blood banks' cryopreservation units
Global utilization of cord blood cells in regenerative medicine
Emerging technologies enhancing public banks' financial sustainability
Expansion services in the realm of cord blood banking
Highlighting the geographical market expanse, the report underscores India's and China's dominant positions, collectively housing over a third of the world's population. Such demographics present vast opportunities for cord blood and tissue banking services. LifeCell International's commanding presence in India, managing over 320,000 stem cell units, exemplifies the regional market's potential.
The U.S landscape has not been left behind in the wave of industry consolidation, with major players like CooperSurgical and Cryoholdco cementing their status through strategic acquisitions. With a focus on enhancing comprehensive cord blood banking services, the industry is witnessing expanded offerings that include reproductive services, genetic testing, and cell therapy product development.
Furthermore, the report identifies the burgeoning market segments within the cord blood and tissue banking sphere, from storage market revenues and the therapeutic use of cord blood in transplantation medicine to the cutting-edge arena of regenerative medicine applications.
Celebrating Scientific Progress and Market Evolution
In a market ripe with scientific innovation, such as the groundbreaking FDA approval of Omisirge for recuperating cancer patients' white blood cells, the industry's potential is unmistakable. Moreover, the diverse application in clinical trials, with over 1,200 studies, illustrates the industry's pivotal role in advancing healthcare.
The strategic report is an indispensable resource for stakeholders looking to navigate the complexities of the cord blood and tissue banking industry. It stands as a testament to the ongoing metamorphosis of this niche yet essential healthcare service, offering a horizon of opportunities for market participants and recipients alike.
Advocating for informed decision-making and strategic positioning within the healthcare sector, this publication is an authoritative guide that equips entities with the knowledge to leverage the unfolding trends and optimize their operational footprint in the cord blood and tissue banking markets.
As the industry continues to evolve, the insights from this report pave the way for informed dialogue, strategic planning, and competitive positioning within the global cord blood and tissue banking landscape.
The report presents findings on the following topics:
Number of cord blood and tissue units cryopreserved in public and private cord blood banks worldwide
Number of hematopoietic stem cell transplants (HSCTs) performed globally using cord blood cells
Utilization of cord blood cells in regenerative medicine clinical trials
The decline of the utilization of cord blood cells in HSCT since 2005
Emerging technologies that will influence the financial sustainability of public cord blood banks
The future scope for companion products derived from cord blood
The changing landscape of the cord blood and tissue banking market
Expansion and extension of services by cord blood banks
Types of cord blood banks
Economic model of public cord blood banks
Cost analysis for public cord blood banks
Economic model of private cord blood banks
Cost analysis for private cord blood banks
Profit margins for private cord blood banks
Pricing for processing and storage in private banks
Rate per cord blood unit in the U.S. and Europe
Indications for the use of cord blood-derived HSCs within transplantation medicine
Diseases targeted by cord blood-derived MSCs in regenerative medicine
Cord blood processing technologies
Number of clinical trials, number of published scientific papers, and amount of NIH funding for cord blood research
Number and types of patents for cord blood, cord tissue, and placental products
Transplantation data from different cord blood registries
Companies Mentioned
AlphaCord
Americord Registry, Inc.
Anja Health Personalized Cord Blood Banking
Anthony Nolan
Be The Match
California Umbilical Cord Collection Program
Carolinas Cord Blood Bank (CCBB)
Celebration Stem Cell Centre (CSCC)
Cell Care
Cells4Life Group LLP
CellSave Arabia
Center for International Blood and Marrow Transplant Research (CIBMTR)
CHOC Blood Bank
ClinImmune Cell and Gene Therapy
Cord Blood Bank of Arkansas (CBBA)
Cord Blood Registry (owned by CooperSurgical)
Cord for Life
CordVida
Crioestaminal
CryoCyte, LLC
Cryolife
Cryopoint
Cryoviva Biotech Pvt., Ltd.
DentCell
DKMS gGMBH
European Society for Blood and Bone Marrow Transplantation (EBMT)
ExCellThera
Future Health
Gamida Cell
HealthBanksUSA
HEMAFUND
IMMUNIQUE
Insception LifeBank
JP McCarthy Cord Stem Cell Bank
Life Line Stem Cell
LifeSouth Cord Blood Bank
Maze Cord Blood
MiracleCord, Inc.
PacifiCord
PBKM FamiCord
Restem, LLC
San Diego Cord Blood Bank
SmartCells
SSM Cardinal Glennon Children's Medical Center
Stem Cell Cryobank, Inc.
Stembanc, Inc.
Upstate Cord Blood Bank
Versity, Inc.
Vitalant Clinical Services
World Marrow Donor Association (WMDA)
Worldwide Network for Blood & Marrow Transplantation (WBMT)
For more information about this report visit https://www.researchandmarkets.com/r/cro7bu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。